Esperion CEO on safety of new cholesterol drug

CNBC's Meg Tirrell reports on Esperion shares heading higher on its new cholesterol drug. Esperion CEO and President Tim Mayleben joins 'Power Lunch' to discuss the new drug and drug pricing.
06:51
Wed, Oct 31 20182:27 PM EST